High-Dose Combined Alkylating Agent Therapy With Autologous Stem Cell Support and Chest Radiotherapy for Limited Small-Cell Lung Cancer

This publication has 17 references indexed in Scilit:

• Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group.
  Journal of Clinical Oncology, 1992
• Intensive weekly chemotherapy for good-prognosis patients with small-cell lung cancer.
  Journal of Clinical Oncology, 1991
• High-dose cyclophosphamide and VP 16 as late dosage intensification therapy for small cell carcinoma of lung
  Cancer Chemotherapy and Pharmacology, 1985
• Current status of therapy for small cell carcinoma of the lung
  Cancer, 1984
• Small cell lung cancer 1973–1983: Early progress and recent obstacles
  International Journal of Radiation Oncology*Biology*Physics, 1984
• Treatment of extensive stage small cell bronchogenic carcinoma
  The American Journal of Medicine, 1983
• Treatment of small cell carcinoma of lung with late dosage intensification programmes containing cyclophosphamide and mesna
  Cancer Treatment Reviews, 1983
• Haematological reconstitution following high dose and supralethal chemo‐radiotherapy using stored, non‐cryopreserved autologous bone marrow
  British Journal of Haematology, 1983
• Cisplatin, adriamycin, and etoposide (cav) for remission induction of small-cell bronchogenic carcinoma. Evaluation of efficacy and toxicity and pilot study of a “late intensification” with autologous bone-marrow rescue
  Cancer, 1982
• Dose: A critical factor in cancer chemotherapy
  The American Journal of Medicine, 1980